gotucream-logo-transparent-2x

FREE & Fast Shipping + 180 Day Money Back Guarantee

FREE & Fast Shipping + 180 Day Money Back Guarantee

Gotucream™Made in Scotland
180 DAYMONEYBACKGUARANTEE
Front of Gotucream 2 oz / 59 ml jar
180 DayMoney BackGuarantee
✓
Eyes, Brightened Brighter look from day 3
3
Days to
first results most customers
★
5 stars on
Trustpilot verified reviews

Dark Circle Cream – Gotucream 2 fl oz

★★★★★5 stars · 2,309 reviews on Trustpilot
Just amazing! Only cream I have used for puffiness and black eye circles that has worked.— Sarah D. · Verified buyer
Choose your jar size

Used daily on a palm-sized area, a 2 fl oz jar lasts about four weeks. The 10 fl oz jar holds five times as much.

Free shipping · arrives in 2–3 days

Our Guarantee

Here's our simple promise to you: if your dark circles do not look better within three days of your first application, you get every cent back. No questions and no hassle. You have 180 days to decide, and returns are free: we email you a prepaid return label.

Got Dark Circles? Do Not Worry!

Dark circles
Gotucream is here to help!

Unlike ordinary dark circles products, you won't have to wait for many days or weeks before seeing your first results. With Gotucream you will see the look of your dark circles remarkably improve within just three days. Gotucream is the result of extensive research with 217 published scientific studies on its botanical ingredients. In addition results are backed by our incredible 100% no questions asked 180 days money back guarantee.

Take control of your skin naturally.

Join 250,000+ Americans taking control of their skin naturally.

★★★★★5 stars from 2,309 Trustpilot reviews
Gotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with GotucreamGotucream customer with Gotucream
Start Your Journey Today
Why Gotucream

10 Things That Make Gotucream The Best Dark Circle Cream

Here are 10 reasons Gotucream is the number one choice for dark circles all over the world:

Fast Results

Ordinary dark circles products make you wait weeks. Gotucream gets to work from the very first application: your dark circles look remarkably better within 3 days, and you have your complete results within 3 weeks.

Natural Ingredients

Six botanicals, chosen from thousands of years of traditional herbal medicine and made in Scotland. 100% natural, nothing harsh.

Backed By Science

Every ingredient earns its place twice: centuries of traditional use, and modern research. Together, the six botanicals are backed by 217 published scientific studies.

Clean Formula

The active botanicals are hand blended into a natural cream base with no parabens and no harsh chemicals. Nothing in the jar you wouldn't want on your skin.

Our Own Recipe

Six botanicals blended to our own proprietary formula, for maximum effect on the look of your dark circles.

Gentle On Skin

A gentle botanical formula. Compare that with the chemical-heavy creams on the shelf.

Feels & Smells Great

Non-greasy, sinks in fast, and smells so good you'll look forward to using it.

For All Severities of Dark Circles

Whether your dark circles showed up last month or have been there for years, Gotucream is the strongest cosmetic cream.

Suitable For Everyone

Every skin type, every skin tone, every age. If you have skin, Gotucream is for you.

180 Day Money Back Guaranteed

Try it for 180 days. Not happy for any reason? Claim a refund with no questions asked. Your purchase is 100% risk free.

Buy Now With 180 Days Guarantee

YOUR GOTUCREAM JOURNEY

Your Dark Circle Timeline

Initial results in 3 days. Complete transformation by week 3.
Close-up showing dark circles
Day 3

Softer to the touch

Skin under your eyes feels smoother and more supple.

Week 1

The change begins

You'll see dark circles start to look brighter.

Week 2

Visibly brighter

The look of dark circles keeps improving.

Week 3

Bare-faced confident

Skip the concealer.

What You’ll See In The End

Guaranteed Results. No Excuses

01

Brightens Dark Circles

Shadows under the eyes look lighter.

02

Evens Under-Eye Tone

Darker areas blend with your skin.

03

Smooths Fine Lines

Under-eye crinkles soften.

04

Awake Look

Your eyes look rested and fresh.

05

Less Concealer

A lighter touch every morning.

06

Bare-Faced Confidence

Skip makeup and still look awake.

DON’T TAKE OUR WORD FOR IT!

Rated 5 Stars on Trustpilot

★★★★★
Unbelievable! It truly works like described- within 2 days my skin appearance totally changed.— Tina S., Florida · Verified buyer
★★★★★
Fabulous beyond belief!! This Worked!!!— Marla Z. · Verified buyer
★★★★★
This cream is awesome! I noticed a difference within 3 days of using this product. I will be ordering again soon.— Cynthia B., South Carolina · Verified buyer
★★★★★
I have tried everything, GotuCream is the winner!— Jacqueline B. · Verified buyer
★★★★★
This cream works. Saw great results the next morning. Highly recommend this cream!— Pam, California · Verified buyer
★★★★★
Performed far better than I could have believed! Thanks for an amazing product!— Vickie S., Texas · Verified buyer
★★★★★
Seriously amazed at the change in my skin after just a few days.— Heidi W., Minnesota · Verified buyer
★★★★★
Worked in 1 and a half days. Perfect.— Julie S., North Carolina · Verified buyer
★★★★★
LOVE this product! I have already bought it 3 times— Shelby, California · Verified buyer
★★★★★
Can't believe that it really works. Would recommend and buy again.— Dvorah · Verified buyer
Buy Now With 180 Days Guarantee
ZBXjqPZYFZUSNneE-11.jpg
THE SCIENCE OF GOTUCREAM

Botanical Science, Clinically Studied

Out of thousands of plants studied in skin research, six stood out, led by Gotu Kola, whose asiaticoside and madecassoside are among the most studied botanical compounds in skincare. All six are in every jar of Gotucream, blended using our own secret recipe for maximum effect, and together they are backed by an astonishing 217 published scientific studies.
1 recipe proprietary, ours alone
3 days to first results
1 jar no 7-step routine
WHAT IS INSIDE

Six Botanicals. One Powerful Secret Recipe.

Gotucream is a unique combination of six botanicals blended together in a specific proprietary proportion according to our unique formula for maximum effect on dark circles.
Gotu Kola botanical

Gotu Kola

Rich in asiaticoside and madecassoside, triterpenoids among the most studied plant compounds in skin research, and the centella asiatica behind the “cica” boom in Korean skincare.

Aloe Vera botanical

Aloe Vera

Carries aloesin and acemannan, compounds studied in published research for an even-looking tone and a smooth, comfortable surface.

Tea Tree botanical

Tea Tree

Its key compound, terpinen-4-ol, is one of the most researched botanical actives for a clear, fresh-looking skin surface.

Neem botanical

Neem

Packed with limonoids and essential fatty acids that help skin look healthy, resilient and well cared for.

Cedarwood botanical

Cedarwood

Its sesquiterpenes, including cedrol, give the blend its grounding character and a balanced, comfortable feel on the skin.

Grapeseed botanical

Grapeseed

Pressed from winemaking seeds and rich in linoleic acid, a building block of the skin barrier, and proanthocyanidins, among the most potent botanical antioxidants studied.

The Science Inside

How Gotucream Works On Dark Circles

Dark circles are not one problem but three, stacked inside the thinnest skin on your body. That is why our unique proprietary formula is built to work on all three layers at once.
incident light≈ 0.5 mm3Stratum corneumsurface creases cast shadowEpidermis1Melanin granulesmelanocytes · basal layerDermiscollagen network · fibroblasts2Venous plexusdeoxygenated bloodOrbicularis oculimuscleFig. 1 Cross-section of under-eye (periorbital) skin, thethinnest skin on the body. Dark circles come from three layers:① pigment, ② blood showing through, ③ surface shadow.
1

Pigment

Periorbital hyperpigmentation
TyrosineDOPADopaquinoneMelanintyrosinasetyrosinaseAloesinstudied on this stepMelanocyteKeratinocytesFig. 2 Melanogenesis: melanin is made in melanocytes,then passed up into the skin cells above.

Deep in the epidermis, melanocytes convert the amino acid tyrosine into melanin through the enzyme tyrosinase, then pass melanin-filled melanosomes up into the surrounding skin cells. When this runs high under the eye, the skin reads brown. Our formula carries aloesin and grape-seed proanthocyanidins, compounds studied in published research for their effect on tyrosinase activity and on oxidative stress respectively, so the look of under-eye pigment fades toward an even tone.

Aloesin · Proanthocyanidins
2

Show-through

Vascular darkness
Thin, loose dermisblue-purple shows throughDenser collagen networkcolor beneath is veiledFig. 3 Light reaching the venous plexus returns blue-purplethrough thin skin; a denser dermis scatters it back first.

Under-eye skin is only about 0.5 mm thick. Beneath it, a network of veins carries deoxygenated blood whose hemoglobin absorbs red light, so through thin skin it reads blue-purple. The denser the dermis above, the more of that color is veiled. Gotu Kola's triterpenoids, asiaticoside and madecassoside, are among the most studied botanical compounds for their effect on collagen production by dermal fibroblasts, helping under-eye skin look denser so less of the color beneath shows through.

Asiaticoside · Madecassoside
3

Shadow

Surface texture
Depleted lipid mortarwater escapes · surface creasesIntact lipid mortarsmooth surface · even reflectionFig. 4 The stratum corneum's brick-and-mortar barrier:corneocytes held in ceramides, cholesterol and fatty acids.

The outer layer, the stratum corneum, is built like a brick wall: skin cells held in a mortar of ceramides, cholesterol and fatty acids. When that mortar thins, water escapes through the skin, the surface creases into fine crepey lines, and every crease catches a shadow that deepens the circle. Our formula supplies linoleic acid from grapeseed, a building block of the barrier's own ceramides, alongside aloe's acemannan, so the surface looks smoother and reflects light evenly instead of casting shadow.

Linoleic acid · Acemannan

Three causes, one jar. That is the science behind our unique proprietary formula.

Compound research refers to published studies on these botanical compounds, not on Gotucream itself.
JOIN THE CHANGE.

Redefining skincare

Support the movement for natural products by only buying products that:

01

Have a long history of traditional use.

02

Use botanical ingredients.

03

Use only relevant ingredients.

04

Are responsibly made.

05

Are validated by real scientific research.

Gotucream is gently blended by hand in Scotland, United Kingdom, using the finest botanical ingredients.

Buy Gotucream today and see the difference in your dark circles for yourself!

WHY US.

5 Facts About the Making of Gotucream

Five things we do that commercial creams don’t. Each one is why Gotucream is different.
01

Protecting the botanicals

Glycerin extraction, not alcohol. Alcohol gives a longer shelf life at the cost of the plant’s delicate compounds.

02

Using the right part

Leaf extract where only the leaf will do. Whole-plant extracts are cheaper, and weaker.

03

A naturally derived base

No synthetic fillers. The six botanicals sit in a naturally derived base, not a chemical one that cuts costs.

04

Slowly hand blended

No machines. Hand blending keeps the structure of each botanical intact, batch by batch.

05

Measured with purpose

No guesswork. Each botanical goes in at a high, meaningful concentration.

✓

180 Day Money Back Guarantee

We make your purchase risk free! If for any reason you are not satisfied, fill in our refund form. It takes less than 30 seconds, and we credit your money back to the card you paid with, no questions asked, even if your jar is empty. Returns cost you nothing: we email you a free prepaid return label. Your purchase is 100% risk free!

Awake Eyes, Every Morning

Most customers feel the difference within 3 days. Pick your jar and start tonight; if you don’t feel it, it’s free.

ASK US ANYTHING

Questions, answered.

How fast will I see results?

Gotucream is designed as a fast-acting cream that goes to work the moment you apply it. You should see your dark circles looking noticeably better within 3 days of your first application, with the complete transformation by week 3. If you don't, return your jar, even if it's empty, for a full refund. Returns are free: we email you a prepaid return label.

How close to my eyes can I apply it?

Pat it onto the area around the eyes only, never on the eyelid or inside the eye, following the directions on the jar.

How do I use it?

Pat a tiny amount under the eyes on clean skin, keeping it out of the eyes. Use daily, following the directions on the jar.

Does it suit all skin types?

Yes. Gotucream is made for every skin type, tone and age. It is for external use; if your skin is sensitive, do a patch test before first use.

What does it feel and smell like?

Rich but not greasy: it sinks in and gets on with its work. The scent is herbal, from the cedarwood and tea tree in the blend.

How long does a jar last?

Used daily on a palm-sized area, a 2 fl oz jar lasts about four weeks. Smaller areas go much further, and the 10 fl oz jar holds five times as much.

Buy Now With 180 Days Guarantee
Contact Us

We'd Love to Hear From You

For a fast response, fill out the form below and we will get back to you promptly.
Contact Form Demo

Get in touch

Tel: 323-310-1712
Email: support@gotucream.com

Hours

Mon–Fri, 9:00 AM – 5:00 PM

USA customer service address

1968 S. Coast Hwy #4344
Laguna Beach, CA 92651

Manufacturer

Herbal Dermals Ltd
12 Cook St, Glasgow G5 8JN
Scotland, United Kingdom

THE BOTANICAL RESEARCH

The science behind Gotucream.

Following is a non-exhaustive list of published research on the ingredients used in Gotucream. The research is cited here as a reference only and is not meant to constitute a substitute for professional medical advice.

  1. Coldren CD, Hashim P, Ali JM, Oh SK, Sinskey AJ, Rha C. Planta Med 2003, 69:725-32
  2. Distante F, Scalise F, Ronaz C, Bonfigli A, Fluhry JW, Berardesca E. International Journal of Cosmetic Science 2002, 24:81-7
  3. Haftek M, Mac Mary S, Bitoux MA, Creidi P, Seite S, Rougier A et al. Exp Dermatol 2008, 17:946-52
  4. Lee J, Jung E, Kim Y, Park J, Park J, Hong S, Kim J, Hyun C, Kim YS, Park D. Planta Med 2006, 72:324-8
  5. Ryu JS, Park SG, Kwak TJ, Chang MY, Park ME, Choi KH, Sung KH, Shin HJ, Lee CK, Kang YS, Yoon MS, Rang MJ, Kim SJ. Skin Res Technol 2005, 11:157-64
  6. Ahshawat MS, Saraf S. Int J Cosmet Sci 2008, 30:183-93
  7. Maquart FX, Bellon G, Giller P, Randoux A, Borel JP. Sem Hop Paris 1989, 65:1571-4
  8. Abdul Hamid A, Shah ZM, Muse R, Mohamed S. Urban Food Chem 2002, 77:465-9
  9. Gnanapragasam A, Ebenezar KK, Sathish V, Govindaraju P, Devaki T. Life Sci 2004, 76:585-97
  10. Jayashree G, Kurup Muraleedhara G, Sudarslal S, Jacob VB. Fitoterapia 2003, 74:431-4
  11. Subathra M, Shila S, Devi MA, Panneerselvam C. Exp Gerontol 2005, 40:707-15
  12. Zainol MK, Abd-Hamid A, Yusof S, Muse R. Urban. Food Chemistry 2003, 81:575-81
  13. Kimura Y, Sumiyoshi M, Samukawa K, Satake N, Sakanaka M. Eur J Pharmacol 2008, 584:415-23
  14. Liu M, Dai Y, Li Y, Luo Y, Huang F, Gong Z, Meng Q. Planta Med 2008, 74:809-15
  15. Mallol J, Belda MA, Costa D, Noval A, Sola M. Int J Cosm Sci 1991, 13:51-7
  16. Shukla A, Rasik AM, Jain GK, Shankar R, Kulshrestha DK, Dhawan BN. J Ethnopharmacol 1999, 65:1-11
  17. Suguna L, Sivakumar P, Chandrakasan G. Indian J Exp Biol 1996, 34:1208-11
  18. Wolfram S. Wien Med Wochenschr 1965, 115: 439-42
  19. Lu L. et al. (2004). Int J Dermatol. 801-7.
  20. Chen YJ, Dai YS, Chen BF, Chang A, Chen HC, Lin YC et al. Biol Pharm Bull 1999, 22:703-6
  21. Klövekorn W, Tepe A, Danesch U. Int J Clin Pharmacol Ther 2007, 45(11):583-91.
  22. Somchit MN, Sulaiman MR, Zuraini A, Samsuddin L, Sonchit N, Israf DA, Moin S. Indian J Pharmacol 2004, 6:377-80
  23. Natarajan S, Paily PP. Ind J Dermatol 1973, 18(4):82-5
  24. Sampson JH, Raman A, Karlsen G, et al. Phytomedicine. 2001;8:230–5
  25. De Sanctis MT, Belcaro G, Incandela L, Cesarone MR, Griffin M, Ippolito E, Cacchio M. Angiology 2001, 52(2):55-9
  26. Guseva G, Stravoitova MN, Mach ES. Ter Arkh. 1998;70:58–61.
  27. Allegra C, Pollari G, Criscuolo A, Bonifacio M, Tabassi D. Clin Ter 1981, 99(5):507-13 [Italian]
  28. Arpaia MR, Ferrone R, Amitrano M, Nappo C, Leonardo G, del Guercio R. Int J Clin Pharmacol Res 1990, 10:229-33
  29. Belcaro GV, Grimaldi R, Guidi G. Angiology 1990, 41(7):533-40
  30. Cataldi A, Gasbarro V, Viaggi R, Soverini R, Gresta E, Mascoli F. Minerva Cardioangiol 2001, 49(2):159-63 [Italian]
  31. Cesarone MR, Belcaro G, De Sanctis MT, Incandela L, Cacchio M, Bavera P, Ippolito E, Bucci M, Griffin M, Geroulakos G, Dugall M, Buccella S, Kleyweght S, Cacchio M. Angiology 2001, 52(2):15-18
  32. Cesarone MR, Belcaro G, Rulo A, Griffin M, Ricci A, Ippolito E, De Sanctis MT, Incandela L, Bavera P, Cacchio M, Bucci M. Angiology 2001, 52(2):45-8
  33. Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Grimaldi R, Marelli C, Belcaro G. Minerva Cardioangiol 1994, 42(6):299-304 [Italian]
  34. Incandela L, Cesarone MR, Cacchio M, De Sanctis MT, Santavenere C, D’Auro MG, Bucci M, Belcaro G. Angiology 2001a, 52(2):9-13
  35. Incandela L, Belcaro G, De Sanctis MT, Cesarone MR, Griffin M, Ippolito E, Bucci M, Cacchio M. Angiology 2001b, 52(2):61-7
  36. Incandela L, Belcaro G, Nicolaides AN, Cesarone MR, De Sanctis MT, Corsi M, Bavera P, Ippolito E, Griffin M, Geroulakos G, Sabetai M, Ramaswami G, Veller M. Angiology 2001c, 52(2):69-73
  37. Marastoni F, Baldo A, Redaelli G, Ghiringhelli L. Minerva Cardioangiol 1982, 30(4):201-7 [Italian]
  38. Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Cochrane Database Syst Rev 2005, 20(3):CD003229
  39. Pointel JP, Boccalon H, Cloarec M, Ledevehat C, Joubert M. Angiology 1987, 38(1):46-50
  40. Wollina U, Abdel-Naser MB, Mani R. 2006, 5:169-80
  41. Alternative Medicine Review. 2007. 12:1, 69-72.
  42. Asakawa Y, Matsuda R, Takemoto T. Phytochemistry 1982, 21:2590-2
  43. Barnes J, Anderson LA and Phillipson JD. Herbal Medicines. 3rd ed. Pharmaceutical press, London 2007, 371-73
  44. Basset A. A new Acquisition in Dermatology – the fatty gauze Madécassol. La Vie Medicale 1978, 2-4
  45. Bhandari P, Kumar N, Gupta AP, Singh B, Kaul VK. J Sep Sci 2007, 30:2092-6
  46. Brinkhaus B, Linder M, Schuppan D, Hahn EG. Phytomedicine 2000, 7:427-48
  47. British Herbal Pharmacopoeia. British Herbal Medicine Association. Exeter 1983, 56-7
  48. Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. I. Indian J Exp Biol 1968, 6:232-47.
  49. EMEA. The Committee for Veterinary Medicinal Products. EMEA/MRL/494 September 1998
  50. ESCOP Monographs 2nd ed. Supplement 2009. European Scientific Cooperative on Phytotherapy, editor. Thieme, Stuttgart 2009
  51. Inamdar PK, Yeole RD, Ghogare AB, de Souza NJ. J Chrom A 1996, 742:127-30
  52. Kartnig T. Clinical applications of Centella asiatica (L.). Herbs Spices Med Plants 1988, 3:145-73
  53. Mohandas Rao KG, Muddanna Rao S, Gurumadhva Rao S. Centella asiatica (L.) Evid Based Compl Alter Med 2006, 3:349-57
  54. Rotblatt M, Ziment I. Hanley & Belfus inc. Medical Publishers, Philadelphia 2001, 227-30
  55. Sahu NP, Subodh KR, Mahato SB. Phytochemistry 1989, 28: 2852-54.
  56. Sathya B, Uthaya Ganga R. 2007. Available at: http://openmed.nic.in
  57. Subban R, Veerakumar A, Manimaran R, Hashim KM, Balachandran I. J Nat Med 2008, 62:369-73
  58. Tiwari KN, Sharma NC, Tiwari V, Singh BD. Plant Cell, Tissue and Organ Culture 2000, 63:179-85
  59. WHO monographs on selected medicinal plants. World Health Organization, Geneva 1999
  60. Williamson EM. Potter’s Cyclopaedia of Botanical Drugs and Preparations. The C.W. Daniel Company Ltd, Essex, England 2003, 229-30
  61. A. vera extract. Full Study: Radha MH, Laxmipriya NP. J Tradit Complement Med. 2015;5(1):21-6.
  62. Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. Trop Med Int Health. 1996;1(4):505-9.
  63. Vardy DA, Cohen AD, Tchetov T, Medvedovsky E, Biton A. J Dermatological Treatment. 1999;10(1):7-11.
  64. Visuthikosol V, Chowchuen B, Sukwanarat Y, Sriurairatana S, Boonpucknavig V. J Med Association Thailand. 1995;78(8):403-9.
  65. Grindlay D, Reynolds T. J Ethnopharmacol. 1986; 16(2–3): 117–51.
  66. Little JW. Complementary and alternative medicine: impact on dentistry. 2004; 98: 137–45.
  67. Morton JF. Econ Bot. 1961; 15: 311–19.
  68. Ahlawat KS, Khatkar BS. 2011; 48: 525–33.
  69. Hamman JH. Molecules. 2008; 13: 1599–616.
  70. Gupta VK, Malhotra S. Ayu. 2012; 33(2): 193–6.
  71. Ghaderi R, Afshar M, Akhbarie H, Golalipour MJ. Int J Morphol. 2010; 28(1): 193–198.
  72. Blanks T. Mind, Body, and Soul: Body Shop Book of Wellbeing. Ebury Press. London, 1998.
  73. Reynolds T, Dweck AC. J Ethnopharmacol. 1999; 68: 3–37.
  74. Boudreau MD, Beland FA. Rev. 2006; 24(1): 103–54.
  75. Molazem Z, Mohseni F, Younesi M, Keshavarzi S. Glob J Health Sci. 2014; 7(1): 203–9.
  76. Paulsen E, Korsholm L, Brandrup F. J Eur Acad Dermatol Venereol. 2005; 19(3): 326–31.
  77. Panahi Y, Sharif MR, Sharif A, Beiraghdar F, Zahiri Z, Amirchoopani G, et al. Scientific World Journal. 2012; 2012: 810234.
  78. Reuter J, Jocher A, Stump J, Grossjohann B, Franke G, Schempp CM. Skin Pharmacol Physiol. 2008; 21(2): 106–110.
  79. Bhattacharya M, Kaur I, Kumar B. J Dermatol. 2000; 27: 576–82.
  80. Rajar UD, Majeed R, Parveen N, Sheikh I, Sushel C. J Coll Physicians Surg Pak. 2008; 18(10): 612–4.
  81. Tanaka M, Misawa E, Ito Y, Habara N, Nomaquchi K, Yamada M, et al. Biol Pharm Bull. 2006; 29(7): 1418–22.
  82. Tanaka M, Misawa E, Yamauchi K, Abe F, Ishizaki C. Clin Cosmet Investig Dermatol. 2015; 8: 95–104.
  83. West DP, Zhu YF. Am J Infect Control. 2003; 31(1): 40–2.
  84. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Arch Dermatol. 2002; 138(11): 1462–70.
  85. Cho S, Lee S, Lee MJ, Lee DH, Won CH, Kim SM, et al. Ann Dermatol. 2009; 21(1): 6–11.
  86. Tatakis DN, Kumar PS. Dent Clin North Am. 2005; 49(3): 491–516.
  87. Gupta S, Jawanda MK. Indian J Dermatol. 2015; 60(3): 222–229.
  88. Sugerman PB, Savage NW, Zhou X, Walsh LJ, Bigby M. Clin Dermatol. 2000; 18: 533–9.
  89. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P. Br J Dermatol. 2008; 158(3): 573–7.
  90. Salazar-Sánchez N, López-Jornet P, Camacho-Alonso F, Sánchez-Siles M. 2010; 39(10): 735–40.
  91. Altenburg A, Zouboulis CC. Skin Therapy Lett. 2008; 13(7): 1–4.
  92. Babaee N, Zabihi E, Mohseni S, Moghadamnia AA. Dent Res J. 2012; 9(4): 381–5.
  93. Vangipuram S, Jha A, Bhashyam M. J Clin Exp Dent. 2016; 8(4): e442-e447.
  94. de Oliveira SM, Torres TC, Pereira SL, Mota OM, Carlos MX. J Appl Oral Sci. 2008; 16(4): 293–6.
  95. Chandrahas B, Jayakumar A, Naveen A, Butchibabu K, Reddy PK, Muralikrishna T. J Indian Soc Periodontol. 2012; 16(4): 543–8.
  96. Warnakulasuriya S, Johnson NW, van der Waal I. J Oral Pathol Med. 2007; 36(10): 575–80.
  97. Sudarshan R, Annigeri RG, SreeVijayabala G. J Oral Pathol Med. 2012; 41(10): 755–61.
  98. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Crit Rev Oral Biol Med. 2003; 14(4): 275–91.
  99. López-Jornet P, Camacho-Alonso F, Molino-Pagan D. J Oral Pathol Med. 2013; 42(4): 295–301.
  100. Saha L. World J Gastroenterol. 2014; 20(22): 6759–73.
  101. Davis K, Philpott S, Kumar D, Mendall M. Int J Clin Pract. 2006; 60(9): 1080–6.
  102. Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, et al. Aliment Pharmacol Ther. 2004; 19(7): 739–47.
  103. Ryan JL. J Invest Dermatol. 2012; 132(3): 985–93.
  104. Haddad P, Amouzgar-Hashemi F, Samsami S, Chinichian S, Oghabian MA. Curr Oncol. 2013; 20(4): e345–8.
  105. Puataweepong P, Dhanachai M, Dangprasert S, Sithatani C, Sawangsilp T, NarkwongL, et al. Asian Biomed. 2009; 3(4): 375–82.
  106. Merchant TE, Bosley C, Smith J, Baratti P, Pritchard D, Davis T, et al. Radiat Oncol. 2007; 2: 45.
  107. Mansouri P, Haghighi M, Beheshtipour N, Ramzi M. Int J Community Based Nurs Midwifery. 2016; 4(2): 119–26.
  108. Wild S, Roglic G, Green A, Sicree R, King H. Diabetes Care. 2004; 27(5): 1047–53.
  109. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Phytomedicine. 1996; 3(3): 241–3.
  110. Yagi A, Hegazy S, Kabbash A, Wahab EA. Saudi Pharm J. 2009; 17(3): 209–15.
  111. Tanzer JM, Livingston J, Thompson AM. J Dent Educ. 2001; 65(10): 1028–37.
  112. Bhati N, Jaidka S, Somani R. J Int Soc Prev Community Dent. 2015; 5(5): 394–9.
  113. Prabhakkar AR, Karuna YM, Yavagal C, Deepak BM. Contemp Clin Dent. 2015; 6(1): S24–31.
  114. Ånséhn, S. 1990. Swed. J. Biol. Med. 2:5-8.
  115. Arweiler, N. B., N. Donos, L. Netuschil, E. Reich, and A. Sculean. 2000. Clin. Oral Investig. 4:70-73.
  116. Banes-Marshall, L., P. Cawley, and C. A. Phillips. 2001. Br. J. Biomed. Sci. 58:139-145.
  117. Bassett, I. B., D. L. Pannowitz, and R. S. Barnetson. 1990. Med. J. Aust. 153:455-458.
  118. Beylier, M. F. 1979. Perfum. Flavourist 4:23-25.
  119. Biju, S. S., A. Ahuja, R. K. Khar, and R. Chaudhry. 2005. Pharmazie 60:208-211.
  120. Bishop, C. D. 1995. J. Essent. Oil Res. 7:641-644.
  121. Blackwell, A. L. 1991. Lancet 337:300.
  122. Blackwell, R. 1991. Br. J. Phytother. 2:26-30.
  123. Bourne, K. Z., N. Bourne, S. F. Reising, and L. R. Stanberry. 1999. Antiviral Res. 42:219-226.
  124. Brand, C., M. A. Grimbaldeston, J. R. Gamble, J. Drew, J. J. Finlay-Jones, and P. H. Hart. 2002. Inflamm. Res. 51:236-244.
  125. Brand, C., S. L. Townley, J. J. Finlay-Jones, and P. H. Hart. 2002. Inflamm. Res. 51:283-289.
  126. Buck, D. S., D. M. Nidorf, and J. G. Addino. 1994. J. Fam. Pract. 38:601-605.
  127. Caelli, M., J. Porteous, C. F. Carson, R. Heller, and T. V. Riley. 2000. J. Hosp. Infect. 46:236-237.
  128. Caldefie-Chézet, F., M. Guerry, J. C. Chalchat, C. Fusillier, M. P. Vasson, and J. Guillot. 2004. Res. 38:805-811.
  129. Carson, C. F., L. Ashton, L. Dry, D. W. Smith, and T. V. Riley. 2001. J. Antimicrob. Chemother. 48:450-451.
  130. Carson, C. F., B. D. Cookson, H. D. Farrelly, and T. V. Riley. 1995. J. Antimicrob. Chemother. 35:421-424.
  131. Carson, C. F., K. A. Hammer, and T. V. Riley. 1995. Microbios 82:181-185.
  132. Carson, C. F., K. A. Hammer, and T. V. Riley. 1996. J. Antimicrob. Chemother. 37:1177-1178.
  133. Carson, C. F., B. J. Mee, and T. V. Riley. 2002. Antimicrob. Agents Chemother. 48:1914-1920. [PMC free article]
  134. Carson, C. F., and T. V. Riley. 1993. Lett. Appl. Microbiol. 16:49-55.
  135. Carson, C. F., and T. V. Riley. 1995. J. Appl. Bacteriol. 78:264-269.
  136. Carson, C. F., and T. V. Riley. 1994. Lett. Appl. Microbiol. 19:24-25.
  137. Cassella, S., J. P. Cassella, and I. Smith. 2002. Int. J. Aromather. 12:2-15.
  138. Chan, C. H., and K. W. Loudon. 1998. J. Hosp. Infect. 39:244-245.
  139. Chand, S., I. Lusunzi, D. A. Veal, L. R. Williams, and P. Caruso. 1994. J. Antibiot. 47:1295-1304.
  140. Chao, S. C., D. G. Young, and C. J. Oberg. 2000. J. Essent. Oil Res. 12:639-649.
  141. Christoph, F., P. M. Kaulfers, and E. Stahl-Biskup. 2000. Planta Med. 66:556-560.
  142. Christoph, F., P. M. Kaulfers, and E. Stahl-Biskup. 2001. Planta Med. 67:768-771.
  143. Christoph, F., E. Stahl-Biskup, and P. M. Kaulfers. 2001. J. Essent. Oil Res. 13:98-102.
  144. Cox, S. D., J. E. Gustafson, C. M. Mann, J. L. Markham, Y. C. Liew, R. P. Hartland, H. C. Bell, J. R. Warmington, and S. G. Wyllie. 1998. Lett. Appl. Microbiol. 26:355-358.
  145. Cox, S. D., C. M. Mann, J. L. Markham, H. C. Bell, J. E. Gustafson, J. R. Warmington, and S. G. Wyllie. 2000. J. Appl. Microbiol. 88:170-175.
  146. Cox, S. D., C. M. Mann, J. L. Markham, J. E. Gustafson, J. R. Warmington, and S. G. Wyllie. 2001. Molecules 6:87-91.
  147. D’Auria, F. D., L. Laino, V. Strippoli, M. Tecca, G. Salvatore, L. Battinelli, and G. Mazzanti. 2001. J. Chemother. 13:377-383.
  148. Davis, A., J. O’Leary, A. Muthaiyan, M. Langevin, A. Delgado, A. Abalos, A. Fajardo, J. Marek, B. Wilkinson, and J. Gustafson. 2005. J. Appl. Microbiol. 98:364-372. [PMC free article]
  149. Dryden, M. S., S. Dailly, and M. Crouch. 2004. J. Hosp. Infect. 56:283-286.
  150. Elsom, G. K. F., and D. Hide. 1999. J. Antimicrob. Chemother. 43:427-428.
  151. Ergin, A., and S. Arikan. 2002. J. Chemother. 14:465-472.
  152. Feinblatt, H. M. 1960. J. Natl. Med. Assoc. 52:32-34. [PMC free article]
  153. Griffin, S. G., S. G. Wyllie, J. L. Markham, and D. N. Leach. 1999. Flav. Fragr. J. 14:322-332.
  154. Groppo, F. C., J. C. Ramacciato, R. P. Simoes, F. M. Florio, and A. Sartoratto. 2002. Int. Dent. J. 52:433-437.
  155. Gustafson, J. E., S. D. Cox, Y. C. Liew, S. G. Wyllie, and J. R. Warmington. 2001. Pathology 33:211-215.
  156. Gustafson, J. E., Y. C. Liew, S. Chew, J. Markham, H. C. Bell, S. G. Wyllie, and J. R. Warmington. 1998. Effects of tea tree oil on Escherichia coli. Lett. Appl. Microbiol. 26:194-198.
  157. Hada, T., S. Furuse, Y. Matsumoto, H. Hamashima, K. Masuda, K. Shiojima, T. Arai, and M. Sasatsu. 2001. Microbios 106(Suppl. 2):133-141.
  158. Hada, T., Y. Inoue, A. Shiraishi, and H. Hamashima. 2003. J. Microbiol. Methods 53:309-312.
  159. Hammer, K. A., C. F. Carson, and T. V. Riley. 2003. J. Appl. Microbiol. 95:853-860.
  160. Hammer, K. A., C. F. Carson, and T. V. Riley. 2004. J. Antimicrob. Chemother. 53:1081-1085.
  161. Hammer, K. A., C. F. Carson, and T. V. Riley. 2000. Chemother. 44:467-469. [PMC free article]
  162. Hammer, K. A., C. F. Carson, and T. V. Riley. 2002. J. Antimicrob. Chemother. 50:195-199.
  163. Hammer, K. A., C. F. Carson, and T. V. Riley. 1999. Antimicrob. Agents Chemother. 43:196. [PMC free article]
  164. Hammer, K. A., C. F. Carson, and T. V. Riley. 1999. J. Appl. Microbiol. 86:446-452.
  165. Hammer, K. A., C. F. Carson, and T. V. Riley. 1998. J. Antimicrob. Chemother. 42:591-595.
  166. Hammer, K. A., C. F. Carson, and T. V. Riley. 2000. Med. Mycol. 38:355-362.
  167. Hammer, K. A., C. F. Carson, and T. V. Riley. 1996. Am. J. Infect. Control 24:186-189.
  168. Hammer, K. A., L. Dry, M. Johnson, E. M. Michalak, C. F. Carson, and T. V. Riley. 2003. Immunol. 18:389-392.
  169. Hart, P. H., C. Brand, C. F. Carson, T. V. Riley, R. H. Prager, and J. J. Finlay-Jones. 2000. Inflamm. Res. 49:619-626.
  170. Humphery, E. M. 1930.Med. J. Aust. 1:417-418.
  171. Inouye, S., T. Takizawa, and H. Yamaguchi. 2001. J. Antimicrob. Chemother. 47:565-573.
  172. Inouye, S., T. Tsuruoka, M. Watanabe, K. Takeo, M. Akao, Y. Nishiyama, and H. Yamaguchi. 2000. Mycoses 43:17-23.
  173. Inouye, S., K. Uchida, and H. Yamaguchi. 2001. Mycoses 44:99-107.
  174. Inouye, S., M. Watanabe, Y. Nishiyama, K. Takeo, M. Akao, and H. Yamaguchi. 1998. Mycoses 41:403-410.
  175. Jackson, R. W., and J. A. DeMoss. 1965. J. Bacteriol. 90:1420-1424. [PMC free article]
  176. Jandourek, A., J. K. Vaishampayan, and J. A. Vazquez. 1998. AIDS 12:1033-1037.
  177. Khalil, Z., A. L Pearce, N. Satkunanathan, E. Storer, J. J. Finlay-Jones, and P. Hart. 2004. J. Investig. Dermatol. 123:683-690.
  178. Klimmek, J. K., R. Nowicki, K. Szendzielorz, M. Kunicka, R. Rosentrit, G. Honisz, and W. Krol. 2002. Mikol. Lekarska 9:93-96.
  179. Koh, K. J., A. L. Pearce, G. Marshman, J. J. Finlay-Jones, and P. H. Hart. 2002. Br. J. Dermatol. 147:1212-1217.
  180. Low, D., B. D. Rawal, and W. J. Griffin. 1974. Planta Med. 26:184-189.
  181. Maruzzella, J. C., and N. A. Sicurella. 1960. J. Am. Pharm. Assoc. 49:692-694.
  182. May, J., C. H. Chan, A. King, L. Williams, and G. L. French. 2000. J. Antimicrob. Chemother. 45:639-643.
  183. Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005. J. Hosp. Infect. 59:113-125.
  184. Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005. J. Hosp. Infect. 59:220-228.
  185. Minami, M., M. Kita, T. Nakaya, T. Yamamoto, H. Kuriyama, and J. Imanishi. 2003. Microbiol. Immunol. 47:681-684.
  186. Mondello, F., F. De Bernardis, A. Girolamo, G. Salvatore, and A. Cassone. 2003. J. Antimicrob. Chemother. 51:1223-1229.
  187. Murtagh, J. G. 1999. vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.
  188. Nelson, R. R. S. 2000. J. Antimicrob. Chemother. 45:549-550.
  189. Nelson, R. R. S. 1997. J. Antimicrob. Chemother. 40:305-306.
  190. Nenoff, P., U.-F. Haustein, and W. Brandt. 1996. Skin Pharmacol. 9:388-394.
  191. Oliva, B., E. Piccirilli, T. Ceddia, E. Pontieri, P. Aureli, and A. Ferrini. 2003. Lett. Appl. Microbiol. 37:185-187.
  192. Pearce, A., J. J. Finlay-Jones, and P. H. Hart. 2005. Inflamm. Res. 54:22-30.
  193. Peña, E. F. 1962. Obstet. Gynecol. 19:793-795.
  194. Penfold, A. R., and R. Grant. 1925. J. R. Soc. New South Wales 59:346-349.
  195. Penfold, A. R., and R. Grant. 1923. J. R. Soc. New South Wales 57:80-89.
  196. Penfold, A. R., and R. Grant. 1924. J. R. Soc. New South Wales 58:117-123.
  197. Raman, A., U. Weir, and S. F. Bloomfield. 1995. Lett. Appl. Microbiol. 21:242-245.
  198. Reichling, J., A. Weseler, U. Landvatter, and R. Saller. 2002. Acta Phytotherapeutica 1:26-32.
  199. Rushton, R. T., N. W. Davis, J. C. Page, and C. A. Durkin. 1997.Lower Extremity 4:113-116.
  200. Satchell, A. C., A. Saurajen, C. Bell, and R. S. Barnetson. 2002. Australas. J. Dematol. 43:175-178.
  201. Schnitzler, P., K. Schön, and J. Reichling. 2001. Pharmazie 56:343-347.
  202. Shapiro, S., A. Meier, and B. Guggenheim. 1994. Oral Microbiol. Immunol. 9:202-208.
  203. Shemesh, A., and W. L. Mayo. 1991. Aust. J. Pharm. 72:802-803.
  204. Sherry, E., H. Boeck, and P. H. Warnke. 2001. Am. J. Infect. Control 29:346.
  205. Shin, S. 2003. B. Arch. Pharmacol. Res. 26:389-393.
  206. Soukoulis, S., and R. Hirsch. 2004. Aust. Dent. J. 49:78-83.
  207. Southwell, I. A., A. J. Hayes, J. Markham, and D. N. Leach. 1993. Acta Hort. 344:256-265.
  208. Syed, T. A., Z. A. Qureshi, S. M. Ali, S. Ahmad, and S. A. Ahmad. 1999. Trop. Med. Int. Health 4:284-287.
  209. Takarada, K. 2005. Oral Dis. 11:115.
  210. Tong, M. M., P. M. Altman, and R. S. Barnetson. 1992. Aust. J. Dermatol. 33:145-149.
  211. Uribe, S., J. Ramirez, and A. Peña. 1985. J. Bacteriol. 161:1195-1200. [PMC free article]
  212. Vazquez, J. A., M. T. Arganoza, D. Boikov, J. K. Vaishampayan, and R. A. Akins. 2000. Rev. Iberoam. Micol. 17:60-63.
  213. Vazquez, J. A., and A. A. Zawawi. 2002. HIV Clin. Trials 3:379-385.
  214. Walker, M. 1972. Curr. Podiatry 1972:7-15.
  215. Walsh, L. J., and J. Longstaff. 1987. Periodontology 8:11-15.
  216. Warnke, P. H., E. Sherry, P. A. Russo, M. Sprengel, Y. Acil, J. P. Bredee, S. Schubert, J. Wiltfang, and I. Springer. 2005. J. Clin. Oncol. 23:1588-1589.
  217. Williams, L. R., V. N. Home, and I. Lusunzi. 1993. Cosmet. Aerosols Toiletries Aust. 7:25-34.
Dark Circle Cream · 2 oz
$54
Buy Now